Researchers are studying if hemangiosarcoma subtypes influence how affected dogs respond to treatment – a step toward precision medicine for these patients.

SUMMARY: Researchers will study the genes that are turned “on” and “off” in feline gastrointestinal lymphoma as a step toward improving the diagnosis of this important cancer.

SUMMARY: Researchers will study whether a combination of oral medication and new tumor vaccine provide survival benefit for dogs diagnosed with osteosarcoma. THE PROBLEM: Osteosarcoma (OS) is the most common...

Researchers will study changes in microRNAs in the blood of dogs enrolled in the Golden Retriever Lifetime Study and diagnosed with hemangiosarcoma to identify early disease biomarkers.

Researchers will study the feasibility of using molecules called microRNAs as an early detection tool for hemangiosarcoma, an often-fatal cancer in dogs.

Researchers will develop early detection and prevention strategies for dogs with diffuse large B-cell lymphoma.

SUMMARY: Researchers will use the latest molecular biology techniques to look for melanoma biomarkers in blood and examine tumor tissue for new potential treatment targets.

Researchers will search for new therapy targets for hemangiosarcoma in dogs to inform the development of much-needed therapies and preventives for this deadly cancer.

Researchers will study the frequency of, and risk factors for, cancer in golden retrievers, using data from the Golden Retriever Lifetime Study and VetCompass health databases.

Researchers are studying the feasibility of an adjunct immunotherapy for large- and giant-breed dogs with osteosarcoma that are not good candidates for cancer surgery or limb amputation.